Meptazinol information

Meptazinol
Clinical data
Trade names	Meptid
AHFS/Drugs.com	International Drug Names
Dependence; liability	Low
Routes of; administration	Oral, IM, IV
ATC code	N02AX05 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); UK: POM (Prescription only);
Pharmacokinetic data
Metabolism	The peak analgesic effect is seen within 30–60 minutes and lasts about 3–4 hours
Elimination half-life	Half-life (1.4–4 hours)
Excretion	The drug is rapidly metabolized to the glucuronide, and mostly excreted in the urine
Identifiers
	IUPAC name (RS)-3-(3-Ethyl-1-methylazepan-3-yl)phenol;
CAS Number	54340-58-8 ; HCl: 59263-76-2 ;
PubChem CID	41049;
ChemSpider	37469 ;
UNII	18Y7S5JKZD; HCl: T62FQ4ZCPA ;
KEGG	D08182 ;
ChEMBL	ChEMBL314437 ;
CompTox Dashboard (EPA)	DTXSID6048543 ;
ECHA InfoCard	100.053.718
Chemical and physical data
Formula	C15H23NO
Molar mass	233.355 g·mol−1
3D model (JSmol)	Interactive image;
Chirality	Racemic mixture
	SMILES OC1=CC=CC(C2(CCCCN(C2)C)CC)=C1;
	InChI InChI=1S/C15H23NO/c1-3-15(9-4-5-10-16(2)12-15)13-7-6-8-14(17)11-13/h6-8,11,17H,3-5,9-10,12H2,1-2H3 ; Key:JLICHNCFTLFZJN-UHFFFAOYSA-N ;
	(what is this?) (verify)

Meptazinol (trade name Meptid) is an opioid analgesic developed by Wyeth in the 1970s.^[1] Indications for use in moderate to severe pain, most commonly used to treat pain in obstetrics (childbirth).

Meptazinol is a 3-phenylazepane derivative, whereas the other phenazepanes like ethoheptazine and proheptazine are 4-phenylazepanes.

A partial μ-opioid receptor agonist, its mixed agonist/antagonist activity affords it a lower risk of dependence and abuse than full μ agonists like morphine. Meptazinol exhibits not only a short onset of action, but also a shorter duration of action relative to other opioids such as morphine, pentazocine, or buprenorphine.^[2]

^ US patent 4197239, Cavalla JF, Shepherd RG, White AC, "Hexahydroazepine, Piperidine and Pyrrolidine Derivatives", issued 1980-04-08, assigned to Wyeth
^ Holmes B, Ward A (1985). "Meptazinol. A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy". Drugs. 30 (4): 285–312. doi:10.2165/00003495-198530040-00001. PMID 2998723. S2CID 208818234.

[1] US patent 4197239, Cavalla JF, Shepherd RG, White AC, "Hexahydroazepine, Piperidine and Pyrrolidine Derivatives", issued 1980-04-08, assigned to Wyeth

[Holmes_1985-2] Holmes B, Ward A (1985). "Meptazinol. A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy". Drugs. 30 (4): 285–312. doi:10.2165/00003495-198530040-00001. PMID 2998723. S2CID 208818234.

Meptazinol information

and 27 Related for: Meptazinol information

Meptazinol

Caprolactam

Paracetamol

Nitrous oxide

Bedinvetmab

Hydromorphone

Carfentanil

Codeine

Cannabidiol

Capsaicin

Hydrocodone

Oxycodone

Kava

Dextromethorphan

Phencyclidine

Cannabis

Buprenorphine

Opium

Ibuprofen

Papaver somniferum

Desomorphine

Metamizole

Ibogaine

Diclofenac

Morphine

Phenylalanine

Menthol